GSK to close Dresden vaccine site, cutting some 650 jobs
SOURCENews reportView the filing ↗
What we know
Location: Dresden, Germany.
Department affected: vaccine manufacturing.
A specific layoff date has not been disclosed.
Based on news reporting.
Summary
GSK is consolidating its vaccine manufacturing to its Canada site and is shuttering its Dresden, Germany vaccine manufacturing facility as part of a $2.5 billion cost-savings campaign. The company confirmed the closure will leave some 650 employees jobless, affecting staff at the Dresden vaccine manufacturing campus. GSK said the move is intended to simplify operations and fully match anticipated future demand sustainably and competitively, and tied it to broader cost-cutting measures announced in July. The article notes other recent program and pipeline changes at GSK but the specific layoff impact referenced is the proposed elimination of roles at the Dresden vaccine site.
GSK plc. cut 650 jobs affecting its vaccine manufacturing team.
That is roughly 0.7% of the 99,000 people GSK plc. employs.
LayoffTalk has tracked 6 layoff events at GSK plc. since September 2025, including 158 jobs documented in official WARN filings, with 4 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Estimated figure based on news reporting. Not yet confirmed by GSK plc..
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at GSK plc.
Recent tracked events at this company.